Multiple Dose Study of the Safety, Tolerability, Pharmacokinetics and Effect on Renal Potassium Clearance
Status:
Completed
Trial end date:
2011-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the safety and tolerability of LY2623091 after
multiple oral dosing in healthy men and women of non-childbearing potential. Two cohorts of
16 subjects will participate in 2 dosing periods. Treatment assignment will be double-blind
for LY2623091 and placebo (negative control), and open label for eplerenone (positive
control).